Intellia Therapeutics (NTLA) Receives a Buy from RBC Capital
In a report released today, Luca Issi from RBC Capital maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report), with a ...
FDA Approves Zevra Therapeutics' MIPLYFFA For Treatment Of Niemann-Pick Disease Type C
Zevra Therapeutics Inc. (ZVRA) said that the U.S. Food and Drug Administration approved MIPLYFFA (MY-PLY-FAH) (arimoclomol) capsules ...
Stockhouse4d
Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer
18, 2024 (GLOBE NEWSWIRE) -- Pharmacosmos A/S, a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anemia, and G1 Therapeutics, Inc.
Yahoo Finance4d
Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer
18, 2024 (GLOBE NEWSWIRE) -- Pharmacosmos A/S, a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anemia, and G1 Therapeutics ...
PR Newswire5d
Monument Therapeutics Announces Grant of UK Patent for Neuroinflammation Compound MT1980
MANCHESTER, England, Sept. 17, 2024 /PRNewswire/ -- Monument Therapeutics, a stratified medicine company developing novel treatments for areas of high unmet need in psychiatry and neurology ...
Business Wire6d
Promising Anti-Tumor Activity and Safety of Ivonescimab in Combination Therapies in CRC, TNBC, and HNSCC Featured at ESMO 2024
MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that data for the novel, potential ...